Live Breaking News & Updates on அமலாக்கம் அறிக்கை

Stay updated with breaking news from அமலாக்கம் அறிக்கை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cipla recalls 7,228 bottles of overactive bladder treatment drug in America


Cipla recalls 7,228 bottles of overactive bladder treatment drug in America
SECTIONS
Last Updated: Jul 25, 2021, 12:27 PM IST
Share
Synopsis
As per the USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
ThinkStock Photos
Drug major
Cipla is recalling 7,228 bottles of Solifenacin Succinate tablets, a medicine used to treat overactive bladder, in the US market due to manufacturing issues. As per the latest Enforcement Report issued by the US Food and Drug Administration (USFDA), the Mumbai-based company is recalling 10 mg, 30-count bottles in the US. ....

Drug Administration , Cipla United States Inc , Solifenacin Succinate , Enforcement Report , New Jersey Based , Cipla United States , சிப்லா ஒன்றுபட்டது மாநிலங்களில் இன்க் , அமலாக்கம் அறிக்கை , புதியது ஜெர்சி அடிப்படையிலானது , சிப்லா ஒன்றுபட்டது மாநிலங்களில் ,